Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Brain Neoplasms 3Parkinson Disease 4, Autosomal Dominant Lewy Body 2Pain, Postoperative 2Pain 2Ovarian Neoplasms 2Neoplasms 2Warts 1Stroke 1Sepsis 1Schwannomatosis 1Prostatic Neoplasms 1Pleural Effusion 1Peritoneal Neoplasms 1Pancreatic Neoplasms 1Pancreatic Cyst 1Neuroinflammatory Diseases 1Neurilemmoma 1Multiple Myeloma 1Metastatic Non-Squamous Non-Small Cell Lung Cancer 1Lymphoma, Non-Hodgkin 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hypoxia 1Hyperthermia 1Hemorrhage 1Glycopyrrolate 1Fallopian Tube Neoplasms 1Esophageal Squamous Cell Carcinoma 1Erectile Dysfunction 1Colorectal Neoplasms 1

Interventions

pembrolizumab 1Saline Solution 1Pemetrexed 1Nivolumab 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Metastatic Non-Squamous Non-Small Cell Lung Cancer × Saline Solution × 90 days × Clear all
NCT07246863 2026-04-21

Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC

CatalYm GmbH

Phase 2 Recruiting
131 enrolled
Other solid neoplasmThoracic

Metastatic Non-Squamous Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡